Vancomycin therapeutics and monitoring: a contemporary approach.
about
In silico toxicology: computational methods for the prediction of chemical toxicityA synthetic adenylation-domain-based tRNA-aminoacylation catalystOptimizing the Clinical Use of VancomycinProspective validation of neonatal vancomycin dosing regimens is urgently needed.Questioning the accuracy of trough concentrations as surrogates for area under the curve in determining vancomycin safety.How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patientsAre vancomycin trough concentrations adequate for optimal dosing?Current and emerging drugs for acute bacterial skin and skin structure infections: an update.Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.Influences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients.The Nephrotoxicity of VancomycinVancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.Junior doctors' preparedness to prescribe, monitor, and treat patients with the antibiotic vancomycin in an Australian teaching hospital.Pharmacokinetics of Vancomycin in Elderly Patients Aged over 80 Years.Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients.Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulationsInterventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis
P2860
Q26749472-67312996-2B32-42AB-A9E7-4130BA1C0E39Q27697390-06BC8478-EE0C-4882-B7B5-3020C907C9EAQ28069334-FF0AA51C-F210-46A6-880A-B148254E6D25Q33906451-F763FC41-4EA1-4CDD-939B-1F8C09C2D5DCQ33949459-BE5F0C82-B915-41C5-8C4F-282C3BB2F233Q34894900-8435433F-5B8F-4683-B731-CB32E731B0A6Q35607704-2CBC1C0A-680D-422F-A30C-CD9AEF6C880DQ37544400-59F452B9-BC67-4B08-B438-87A1D2039063Q38242081-D5C0F017-8BF9-42FB-98D2-2B968401CEDFQ38258649-077EFAA1-7C96-4F91-B412-D23B84C9D165Q38610672-55D41EB2-546D-43A1-834E-3F3688A9E516Q38687487-34AD1873-7055-4E57-BF22-24F65066BD4AQ38818376-D9E16A71-00E4-40F1-B6FF-B37E34903364Q40138068-AB977397-2BD3-42D0-81E2-67F2676B5D98Q40672214-4AD52B2C-B4C2-4030-8FD9-53AC8D121CDBQ48765958-40AE9B2E-0336-4AE7-9E17-0CB06B215E1EQ58699337-67F055D1-FC1A-44DE-A539-DAE4B4C2AD8DQ59125936-5503B43F-C33E-4481-AA69-0473F9131855
P2860
Vancomycin therapeutics and monitoring: a contemporary approach.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vancomycin therapeutics and monitoring: a contemporary approach.
@en
type
label
Vancomycin therapeutics and monitoring: a contemporary approach.
@en
prefLabel
Vancomycin therapeutics and monitoring: a contemporary approach.
@en
P2093
P2860
P50
P356
P1476
Vancomycin therapeutics and monitoring: a contemporary approach
@en
P2093
N E Holmes
S J van Hal
P2860
P304
P356
10.1111/IMJ.12036
P577
2013-02-01T00:00:00Z